Hematologic Malignancy
Grade 3b Follicular Lymphoma
CI-CAN-00007775FLBCLExplore in graph →
Hematologic26 active trials
- NCIt
- C7192
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00007775FLBCLExplore in graph →
Clinical trials
40 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (5)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01852435 | R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3B | unknown | Phase 3 | 648 | Ruijin HospitalOTHER | 1 | Nov 14, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Nov 14, 2017source: clinicaltrials